Indefinite Delivery Contract 12305B21D0003

Award Date 3/12/21
Last Date to Order 3/12/22
Funding Federal Agency
Department of Agriculture
Contracting Federal Agency
Northeast Area
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the United States Department of Agriculture (USDA) to Epoch Life Science Inc., a biotechnology company that specializes in providing custom gene synthesis and related services to support federal agricultural research programs. The contract, valued at $600,000, enables the USDA's Agricultural Research Service (ARS) to efficiently procure Epoch Life Science's specialized gene synthesis, site-directed mutagenesis, subcloning, and sequence...
The U.S. Department of Agriculture's Agricultural Research Service (USDA ARS) awarded an Indefinite Delivery Contract (IDC) to Epoch Life Science Inc., a biotechnology company, to provide custom gene synthesis, site-directed mutagenesis, subcloning, and sequence verification services. This single-award IDC has a ceiling value of $300,000 and a period of performance from March 27, 2018 to April 1, 2021, with no set-aside designations. Through various firm-fixed price delivery orders issued...
The USDA Agricultural Research Service awarded a single-award indefinite delivery/indefinite quantity contract to Epoch Life Science Inc. with a potential value of $480,361. The IDV aims to procure custom gene synthesis services in support of the agency's agricultural research programs. A firm fixed price delivery order valued at $168,133.24 was subsequently placed against the IDV. This order requires Epoch Life Science to provide custom gene synthesis services, with all work to be performed...
The Department of Agriculture Animal and Plant Health Inspection Service Plant Protection and Quarantine awarded Functional Biosciences, Inc. a blanket purchase agreement to streamline procurement of DNA sequencing, gene synthesis, molecular biology and genomic services. The single award agreement has a potential value of $300,000 over five years to support plant protection and quarantine programs. Multiple call orders have been placed against the blanket purchase agreement for supplies such...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Agriculture (USDA) Agricultural Research Service to CD Biosciences Inc., a small business provider of genomic sequencing and bioinformatics services. The $109,730 single-award IDC, set aside for small businesses, has a period of performance from June 2022 through June 2024. The contract aims to procure next-generation DNA and RNA sequencing, as well as related bioinformatic analyses, to support ongoing agricultural...
The key products and services being delivered under this federal contract IDV award are Sanger sequencing services provided by Psomagen Inc. to the U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) Plant Protection and Quarantine (PPQ) National Identification Service (NIS). Psomagen, a for-profit manufacturer of goods, holds a single-award IDV valued at $80,000 to provide these sequencing services, which support the agency's efforts to identify...
This Indefinite Delivery Contract was awarded by the U.S. Department of Agriculture (USDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $35,000,000 and a period of performance through May 25, 2025. Under this contract, Illumina provides a range of laboratory equipment, consumables, and services to support the USDA's research and diagnostic needs. This includes the provision of Illumina's NextSeq, NovaSeq,...
This indefinite delivery contract was awarded by the USDA Agricultural Research Service (ARS) Field Research Implementation and Information Delivery (FRIID) Pacific West Area to Azenta US Inc., doing business as Brooks Life Sciences Inc., for DNA sequencing services. The single-award IDIQ contract has a ceiling value of $337,920 and a period of performance through September 2028. Under this contract, Azenta has been issued two firm fixed price delivery orders valued at $15,360 each to provide...
Pacific Biosciences of California, Inc. has been awarded a $13.5 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract by the USDA Agricultural Research Service to provide specialized scientific equipment, reagents, and services associated with the company's Sequel and Sequel II DNA/RNA sequencing platforms. This long-term contract vehicle allows the USDA to issue multiple delivery orders for PacBio's high-throughput, long-read sequencing systems, consumables, and...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Agriculture (USDA) to Illumina, Inc., a leading manufacturer and provider of genetic sequencing and genomic analysis technologies. The contract, valued at a ceiling of $45,000,000, provides the USDA with a wide range of Illumina's genomic sequencing platforms, reagents, consumables, maintenance services, and technical support. The contract covers a 5-year base period with a 5-year option, extending the period of...
  • 12305B21D0003
    Indefinite Delivery Contract
  • 5
    Federal Contract Awards

The Department of Agriculture awarded a single award indefinite delivery contract to Epoch Life Science Inc. with a potential value of $960,000 to purchase custom gene synthesis in support of foreign animal disease research at Plum Island Center. No set-aside was used. The contract includes a period of performance through March 2022 for the issuance of delivery orders.

The originating pre-solicitation sought sources capable of providing gene synthesis services to support the Foreign Animal Disease Research Unit's molecular biology research and plasmid biorepository. Responses assisted the government in determining acquisition methods and the possibility of set-asides. The pre-solicitation described research requiring recombinant plasmids with specific viral protein mutations to evaluate unknown protein functions and inform rational vaccine development. Capability statements from small businesses were requested detailing relevant experience and qualifications.

Generated 1/5/24, 9:08 PM